A cute exposure to alveolar hypoxia triggers reversible hypoxic pulmonary vasoconstriction (HPV), whereas prolonged exposure, as occurring in high-altitude inhabitants or in patients with respiratory diseases, causes pulmonary hypertension (PH). PH is characterized by potentiated vascular tone, altered reactivity to agonists, and profound vascular remodeling, eventually leading to right heart (RV) hypertrophy and failure.
A cute exposure to alveolar hypoxia triggers reversible hypoxic pulmonary vasoconstriction (HPV), whereas prolonged exposure, as occurring in high-altitude inhabitants or in patients with respiratory diseases, causes pulmonary hypertension (PH). PH is characterized by potentiated vascular tone, altered reactivity to agonists, and profound vascular remodeling, eventually leading to right heart (RV) hypertrophy and failure. 1 Although the mechanism of pathogenesis is complex, the intrinsic changes in Ca 2+ homeostasis in pulmonary arterial smooth muscle cells (PASMCs) are the major determinants contributing to PASMC proliferation and vasoconstriction in chronic hypoxic pulmonary hypertension (CHPH). 2 Cytosolic Ca 2+ concentration is regulated by intracellular Ca 2+ release and extracellular Ca 2+ influx, which is gated by voltagedependent Ca 2+ channels and voltage-independent nonselective cation channels. There is growing evidence supporting the pivotal role of multiple nonselective cation channels in acute 3 and prolonged hypoxic responses. [4] [5] [6] Transient receptor potential (TRP) proteins encode a large repertoire of nonselective cation channels in vascular smooth muscle cells. 7 We have previously identified the TRP channels of classical/canonical (TRPC)-, melastatin-, and vanilloid-related subfamilies in rat PASMCs. 4, 8 Functional studies show that TRPC1 and TRPC6 mediate store-operated and receptor-operated Ca 2+ entry, respectively. 4 Most importantly, chronic hypoxia (CH) upregulates the expression of TRPC1 and TRPC6, as well as the associated store-operated and receptor-operated Ca 2+ entry in rat distal pulmonary arteries (PAs). 4 A subsequent study confirmed the upregulation of TRPC1 and TRPC6 expression in the murine model of CHPH and suggested that the process requires the full expression of hypoxia-inducible factor-1α. 9 Abnormalities in TRPC 2 Hypertension January 2014
expression have also been identified in various types of PH. For example, PASMC of idiopathic pulmonary arterial hypertension patients excessively expresses TRPC3 and TRPC6, resulting in augmented store-operated Ca 2+ entry and proliferation. 10 In monocrotaline-induced PH, increased TRPC1 expression and store-operated Ca 2+ entry contribute to the enhanced vasoconstriction to endothelin-1. 11 Additionally, treatment of experimental PH with sildenafil and sodium tanshinone IIA sulfonate suppresses TRPC1 and TRPC6 expression. 12, 13 All of the information hints that TRPC1 and TRPC6 are critically involved in CHPH, but leaves open the question of whether the altered expression and functions of these TRPC channels are essential for the development of the disease. The present study was undertaken to address these issues by using TRPC1-(Trpc1 −/− ), TRPC6-(Trpc6 −/− ), and TRPC1-TRPC6-(Trpc1 −/− Trpc6 −/− ) null mice to examine how TRPC1 and TRPC6 channels affect vasomotor tone, agonist-induced vasoconstriction, and pulmonary vascular remodeling, and whether genetic deletion of these two cation channels could prevent the animals from developing CHPH.
Materials and Methods

Models of CHPH Trpc1
−/− and Trpc6 −/− mice (1:1; 129Sv:C57BL/6J background) were initially provided by the NIEHS Comparative Medicine Branch. 14, 15 Corresponding wild-type (WT) mice of the same background were used as control. Subsequent generations of colonies and Trpc1
Trpc6
−/− mice were maintained at Johns Hopkins University. Age-matched, male WT and knockout mice (10-12 weeks old) were placed in a hypoxic chamber and exposed to 10% O 2 for 1 or 3 weeks to induce hypoxic PH. 16 All procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Johns Hopkins Animal Care and Use Committee (see online-only Data Supplement for details). , and WT mice was compared by real-time RT-PCR. In WT PAs, the mRNA level of TRPC1 was the highest, followed by TRPC6 and then TRPC3, whereas TRPC4, 5, and 7 expressions were minimal. Similar TRPC mRNA expression profiles were found in Trpc1 −/− and Trpc6 −/− PAs, except they were devoid of TRPC1 and TRPC6 mRNA, respectively ( Figure 1A and 1B) . Similar to previous observations in CH rats and mice, 4,9 TRPC1 and TRPC6 protein levels were significantly increased by 246±51% (n=6) and 103±38% (n=6), respectively, in PAs of WT mice exposed to 3 weeks of 10% O 2 ( Figure 1C and 1D ). Comparable increases in TRPC1 (167±31%; n=3) and TRPC6 proteins (110±33%; n=6) were observed in PAs of CH Trpc6 −/− and Trpc1 −/− mice, respectively ( Figure 1E and 1F). These results suggest that there is no compensatory shift in TRPC expression, and the hypoxic regulation of TRPC expression is unaltered in PAs of the knockout mice. 
Results
TRPC Expression in
Deletion of TRPC1 or TPRC6 Suppresses CHPH
TRPC1 and TRPC6 Contribute to CH-Induced Pulmonary Vascular Remodeling
Morphological analysis showed that the percent distributions of nonmuscularized, partially muscularized, and completely muscularized small vessels (<100 μm) were similar in normoxic WT, Trpc1 −/− , and Trpc6 −/− mice ( Figure 3A ). Significant increase in partially (normoxia, 14.9±3.0%; CH, 30.1±5.2%; P<0.01) and completely muscularized vessels (normoxia, 4.3±0.9%; CH, 11.9±2.2%; P<0.01) was observed in CH WT mice. In contrast, there was no significant reduction in the nonmuscular vessels or increase in the partially muscularized vessels, except a marginal increase in the completely muscularized vessels of CH Trpc1 −/− and Trpc6 −/− mice. Furthermore, vessel density was significantly reduced in CH WT mice, and similar reduction was observed in CH Trpc1
and Trpc6 −/− mice ( Figure 3B ). These results clearly indicate that TRPC1 and TRPC6 are important contributing factors to CH-induced neomuscularization of small PAs, but have little influence on rarefraction of small PAs in CHPH.
TRPC1 and TRPC6 Contribute Differentially to Pulmonary Vascular Tone
We devised a strategy to estimate vascular tone at different preloads by measuring the active and passive wall tension of size-matched (ID ≈200 μm) PA rings using a wire myograph. Increasing vessel width from the resting position (zero tension) in 50-μm steps was associated with progressive increase in wall tension ( Figure 4A and Figure S1 in the online-only Data Supplement). Active tension at each point was determined by subtracting total wall tension by passive tension measured after complete relaxation by Ca 2+ removal and addition of papaverine (10 μmol/L; Figure 4B ). The vessel width versus tension relation shows significant active tone in normoxic WT PAs, and it increased with vessel width in a quasilinear manner ( Figure 4C ). Active tension was significantly enhanced in PAs of CH WT mice and abolished by Ca 2+ removal. Stretch-activated spontaneous contractions were observed occasionally in CH WT PAs ( Figure S2 ). Compared with normoxic WT PAs, vascular 
−/− mice ( Figure 4F ). But the enhancement was blunted in CH Trpc1 −/− PAs. These results suggest that TRPC6 is important for maintaining the basal tone under normoxic condition, and TRPC1 plays a crucial role in CH-induced enhancement of pulmonary vascular tone. 
TRPC1 and TRPC6 Contribute to Pulmonary Vasoreactivity in CH PAs
Trpc6
−/− mice compared with WT, whereas heart rate and mean systemic arterial pressures were the same (Figure 6A-6E 
Discussion
In the present study, we used genetic mouse models to test the hypothesis that TRPC1 and TRPC6 are crucial for CHPH development, and to examine their roles in pulmonary vascular functions. Trpc1 −/− and Trpc6 −/− mice are suitable for these purposes because the expressions of TRPC subtypes in PA are , and their regulation by CH is similar to that in rats and WT mice. 4, 9 Our results show that TRPC1 and TRPC6 participate differentially in the three salient features of PH: elevated pulmonary vasomotor tone, altered vascular reactivity, and vascular remodeling. Ablation of TRPC1 or TRPC6 has minimal effect on pulmonary circulation under normoxic conditions, but mitigates PH and RV hypertrophy induced by CH.
We established a strategy for studying vasomotor tone at different muscle length in murine small PA, and much novel information has been revealed. In contrast to the lack of basal vasomotor tone in normoxic rat microvessels, 5,17 murine PA exhibits a small component of active tone. This active tone is myogenic and Ca 2+ -dependent, judging by the increase in magnitude with mechanical stretch and by its complete inhibition after Ca 2+ removal. The vascular tone was enhanced after 3-week CH, similar to the de novo appearance of myogenic tone in PAs of CH rats. 5, 17 Interestingly, the basal tone in normoxic PAs and the CH-enhanced vasomotor tone are apparently two separate components mediated by different mechanisms. Deletion of TRPC6 suppressed the basal tone in normoxic PAs, but did not interrupt the CH-induced elevation in vasomotor tone. The reduction in vasomotor tone of Trpc6 −/− PAs is consistent with reports showing that TRPC6 is mechanosensitive and mediates myogenic response, 18, 19 but it is in contrast to the enhanced myogenic tone in Trpc6 −/− cerebral arteries where compensatory upregulation of TRPC3 is evident. 15 Compared with TRPC6, deletion of TRPC1 has little effect on the vascular tone of normoxic PAs at the lower vessel width, but eliminated the increase in active tone at the higher levels of mechanical stretch. This is consistent with findings that TRPC1 is mechanosensitive in nonvascular cells, 20 but it does not play a significant role in myogenic tone under normal physiological conditions. 14 More importantly, the disappearance of enhanced tone in CH Trpc1 −/− PA suggests that TRPC1 is recruited to facilitate the enhanced vascular tone under pathological conditions of CHPH. This is in concordance with previous reports suggesting that TRPC1 upregulation is responsible for the elevated basal tone in CH rat PAs and resting Ca 2+ concentration of hypoxic PASMCs. 4, 9, 12 A wealth of data has been accumulated suggesting alterations of vasoreactivity of CH rat PAs in response to agonists. 5-HT elicited enhanced contractile response in PAs of our CH WT mice, after normalization with maximal KCl-induced contraction to account for changes in other nonreceptordependent mechanisms. This is consistent with previous reports on CH rats and mice. 6, 21 Moreover, the CH-enhanced 5-HT response was noticeably suppressed in Trpc1 −/− PAs and virtually abolished in Trpc6 −/− PAs, suggesting that TRPC1 plays a contributing role whereas TRPC6 is required for the enhanced response. The clear participation of TRPC6 and TRPC1 in 5-HT-induced contraction in hypoxic but not normoxic PA could be related to the upregulation of the TRPC channels, and it may also reflect changes in the signaling mechanism. 5-HT-induced pulmonary vasoconstriction is mediated primarily by 5-HT 2A and to a lesser extent by 5-HT 1B receptor in normoxic PAs. 21, 22 5-HT 1B and 5-HT 2B expressions are upregulated and the contribution of 5-HT 1B to pulmonary vasoconstriction is augmented in CH PAs. 21, 23 It will be C) ; heart rate (D); and mean arterial pressure (MAP; E); n=9 to 33 in each group. F, Proportion of non-(<25%), partially (25%-75%), and completely (>75%) muscularized resistance pulmonary vessels (<100 μm). G, Quantification of pulmonary vascular densities after 3-week normoxic or hypoxic exposure in DKO and WT mice; n=4 to 9; *P<0.05; **P<0.01; ***P<0.001 vs WT or as specified.
by guest on July 11, 2017 http://hyper.ahajournals.org/ Downloaded from interesting for future studies to investigate whether 5-HT 1B or 5-HT 2B receptors are preferentially coupled to the upregulated TRPC6 channels in CH PAs. TRPC1 and TRPC6 both play a significant role in neomuscularization of small PAs, which was largely suppressed in CH Trpc1 −/− and Trpc6 −/− mice. This is consistent with the wellrecognized roles of TRPC1 and TRPC6 in PASMC proliferation. 10, 24 Lessening of muscularization may reduce PA vasomotor tone and reactivity and hence attenuates PH in CH Trpc1 −/− and Trpc6 −/− mice. It is noteworthy that CH caused a 30% to 40% reduction in the density of pulmonary microvessels, which could lead to an increase in parallel resistance of pulmonary circulation and elevate PAP. Pulmonary vascular rarefaction is well documented in CH rats and mice and is related to alterations in VEGF and other signaling pathways. 25, 26 This process, however, is independent of TRPC1 and TRPC6 because deletion of either or both channels did not reverse the vascular regression.
The contributions of TRPC1 and TRPC6 to CHPH are different at various stages of the disease. For example, PH and RV hypertrophy was greatly suppressed in Trpc6 −/− mice exposed for 1-week hypoxia, but the suppression was diminished after 3 weeks. The early suppression of PH in Trpc6 −/− mice may suggest the TRPC6-dependent vasoreactivity is a major factor in the early development of PH. But it is more likely related to the important role of TRPC6 in HPV. It has been shown that acute hypoxia activates TRPC6 in PASMCs through diacylglycerol accumulation, and HPV is completely abolished in Trpc6 −/− mice. 3, 27 Because HPV occurs immediately after exposure to hypoxia and is blunted within a week after prolonged exposure to hypoxia, 28, 29 the impact of TRPC6-mediated HPV on PAP and RV hypertrophy should be most prominent in the first week of CH and subside thereafter as PH progresses. This is congruent with the observations in CH Trpc6 −/− mice. Whereas, TRPC1 is engaged in the development of the intrinsic vasomotor/myogenic tone, which continues to affect PAP throughout CH exposure. Hence, PH was consistently suppressed in Trpc1 −/− mice after 1 and 3 weeks of CH. TRPC1 and TRPC6 double-deletion experiments provided further insights into the combined influence of these TRPC channels in pulmonary vasculatures. The hypotension of pulmonary circulation observed in normal Trpc1 
Perspectives
This study showed that TRPC1 and TRPC6 are crucial for the regulation of vasomotor tone, vasoreactivity, and neomuscularization of pulmonary vasculatures. These vascular functions contribute at different stages of CHPH, and their participations are essential for the full manifestation of CHPH in the murine model. In view of their multifaceted contributions to PH, manipulation of TRPC functions may offer a promising therapeutic strategy for hypoxia-related PH. 
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